Miguel Carracedo1, Gonzalo Artiach1, Anna Witasp2, Joan Clària3,4, Mattias Carlström5, Andres Laguna-Fernandez1, Peter Stenvinkel2, Magnus Bäck1,6. 1. Translational Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 2. Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. 3. Department of Biochemistry and Molecular Genetics, Hospital Clínic-IDIBAPS, Barcelona, Spain. 4. Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain. 5. Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. 6. Division of Valvular and Coronary Disease, Theme Heart and Vessels, Karolinska University Hospital, Stockholm, Sweden.
Abstract
AIMS: Vascular calcification, a marker of increased cardiovascular risk, is an active process orchestrated by smooth muscle cells. Observational studies indicate that omega-3 fatty acids protect against vascular calcification, but the mechanisms are unknown. The G-protein coupled receptor ChemR23 transduces the resolution of inflammation induced by the omega-3-derived lipid mediator resolvin E1. ChemR23 also contributes to osteoblastic differentiation of stem cells and bone formation, but its role in vascular calcification is unknown. The aim of this study was to establish the role of ChemR23 in smooth muscle cell fate and calcification. METHODS AND RESULTS: Gene expression analysis in epigastric arteries derived from patients with chronic kidney disease and vascular calcification revealed that ChemR23 mRNA levels predicted a synthetic smooth muscle cell phenotype. Genetic deletion of ChemR23 in mice prevented smooth muscle cell de-differentiation. ChemR23-deficient smooth muscle cells maintained a non-synthetic phenotype and exhibited resistance to phosphate-induced calcification. Moreover, ChemR23-deficient mice were protected against vitamin D3-induced vascular calcification. Resolvin E1 inhibited smooth muscle cell calcification through ChemR23. Introduction of the Caenorhabditis elegans Fat1 transgene, leading to an endogenous omega-3 fatty acid synthesis and hence increased substrate for resolvin E1 formation, significantly diminished the differences in phosphate-induced calcification between ChemR23+/+ and ChemR23-/- mice. CONCLUSION: This study identifies ChemR23 as a previously unrecognized determinant of synthetic and osteoblastic smooth muscle cell phenotype, favouring phosphate-induced vascular calcification. This effect may be of particular importance in the absence of ChemR23 ligands, such as resolvin E1, which acts as a calcification inhibitor under hyperphosphatic conditions. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Vascular calcification, a marker of increased cardiovascular risk, is an active process orchestrated by smooth muscle cells. Observational studies indicate that omega-3 fatty acids protect against vascular calcification, but the mechanisms are unknown. The G-protein coupled receptor ChemR23 transduces the resolution of inflammation induced by the omega-3-derivedlipid mediator resolvin E1. ChemR23 also contributes to osteoblastic differentiation of stem cells and bone formation, but its role in vascular calcification is unknown. The aim of this study was to establish the role of ChemR23 in smooth muscle cell fate and calcification. METHODS AND RESULTS: Gene expression analysis in epigastric arteries derived from patients with chronic kidney disease and vascular calcification revealed that ChemR23 mRNA levels predicted a synthetic smooth muscle cell phenotype. Genetic deletion of ChemR23 in mice prevented smooth muscle cell de-differentiation. ChemR23-deficient smooth muscle cells maintained a non-synthetic phenotype and exhibited resistance to phosphate-induced calcification. Moreover, ChemR23-deficient mice were protected against vitamin D3-induced vascular calcification. Resolvin E1 inhibited smooth muscle cell calcification through ChemR23. Introduction of the Caenorhabditis elegansFat1 transgene, leading to an endogenous omega-3 fatty acid synthesis and hence increased substrate for resolvin E1 formation, significantly diminished the differences in phosphate-induced calcification between ChemR23+/+ and ChemR23-/- mice. CONCLUSION: This study identifies ChemR23 as a previously unrecognized determinant of synthetic and osteoblastic smooth muscle cell phenotype, favouring phosphate-induced vascular calcification. This effect may be of particular importance in the absence of ChemR23 ligands, such as resolvin E1, which acts as a calcification inhibitor under hyperphosphatic conditions. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Francis M Hughes; Shelby N Harper; Brent D Nosé; Armand Allkanjari; Michael T Zheng; Huixia Jin; J Todd Purves Journal: Am J Physiol Renal Physiol Date: 2021-08-16
Authors: Francine K Welty; Fabian Schulte; Abdulhamied Alfaddagh; Tarec K Elajami; Bruce R Bistrian; Markus Hardt Journal: FASEB J Date: 2021-04 Impact factor: 5.191
Authors: Gonzalo Artiach; Miguel Carracedo; Till Seime; Oscar Plunde; Andres Laguna-Fernandez; Ljubica Matic; Anders Franco-Cereceda; Magnus Bäck Journal: Cells Date: 2020-03-11 Impact factor: 6.600
Authors: M Carracedo; A Witasp; A R Qureshi; A Laguna-Fernandez; T Brismar; P Stenvinkel; M Bäck Journal: J Intern Med Date: 2019-07-07 Impact factor: 8.989
Authors: Nathalie Mercier; Sven-Christian Pawelzik; John Pirault; Miguel Carracedo; Oscar Persson; Bastien Wollensack; Anders Franco-Cereceda; Magnus Bäck Journal: Oxid Med Cell Longev Date: 2020-01-14 Impact factor: 6.543
Authors: Thomas Ebert; Sven-Christian Pawelzik; Anna Witasp; Samsul Arefin; Sam Hobson; Karolina Kublickiene; Paul G Shiels; Magnus Bäck; Peter Stenvinkel Journal: Toxins (Basel) Date: 2020-04-04 Impact factor: 4.546
Authors: Alexander Mocker; Karl F Hilgers; Nada Cordasic; Rainer Wachtveitl; Carlos Menendez-Castro; Joachim Woelfle; Andrea Hartner; Fabian B Fahlbusch Journal: Int J Mol Sci Date: 2019-12-11 Impact factor: 5.923